Anne‐Lise Børresen‐Dale

2.1k total citations
17 papers, 627 citations indexed

About

Anne‐Lise Børresen‐Dale is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Anne‐Lise Børresen‐Dale has authored 17 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Anne‐Lise Børresen‐Dale's work include Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Anne‐Lise Børresen‐Dale is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (2 papers). Anne‐Lise Børresen‐Dale collaborates with scholars based in Norway, United States and Switzerland. Anne‐Lise Børresen‐Dale's co-authors include Dagny Faksvåg Haugen, Stephanie Geisler, Per Eystein Lønning, Turid Aas, Hilde Johnsen, Øystein Fluge, Lars A. Akslen, J.R. Lillehaug, Kaja Sverdrup Borge and Frode Lingaas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Anne‐Lise Børresen‐Dale

15 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne‐Lise Børresen‐Dale Norway 11 323 315 262 87 76 17 627
Stefan C. Dentro United Kingdom 10 272 0.8× 165 0.5× 240 0.9× 60 0.7× 72 0.9× 13 498
Nurten Yigit Belgium 15 577 1.8× 264 0.8× 282 1.1× 54 0.6× 100 1.3× 29 864
J. R. Marks United States 6 407 1.3× 375 1.2× 203 0.8× 78 0.9× 100 1.3× 7 728
A S Yang United States 5 569 1.8× 278 0.9× 136 0.5× 91 1.0× 79 1.0× 6 734
George Koutsodontis Greece 12 356 1.1× 402 1.3× 201 0.8× 47 0.5× 35 0.5× 20 674
Marco Petronio France 4 166 0.5× 407 1.3× 313 1.2× 37 0.4× 46 0.6× 5 567
Zsuzsa Rákosy Hungary 15 277 0.9× 259 0.8× 137 0.5× 51 0.6× 25 0.3× 23 511
Emily Yun‐Chia Chang Canada 10 364 1.1× 306 1.0× 143 0.5× 41 0.5× 39 0.5× 15 704
Daniel S. Kong United States 9 341 1.1× 224 0.7× 110 0.4× 51 0.6× 40 0.5× 14 568
David Brocks Germany 10 584 1.8× 151 0.5× 266 1.0× 61 0.7× 76 1.0× 14 807

Countries citing papers authored by Anne‐Lise Børresen‐Dale

Since Specialization
Citations

This map shows the geographic impact of Anne‐Lise Børresen‐Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Lise Børresen‐Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Lise Børresen‐Dale more than expected).

Fields of papers citing papers by Anne‐Lise Børresen‐Dale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Lise Børresen‐Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Lise Børresen‐Dale. The network helps show where Anne‐Lise Børresen‐Dale may publish in the future.

Co-authorship network of co-authors of Anne‐Lise Børresen‐Dale

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Lise Børresen‐Dale. A scholar is included among the top collaborators of Anne‐Lise Børresen‐Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Lise Børresen‐Dale. Anne‐Lise Børresen‐Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nygaard, Vigdis, Anne Hansen Ree, Vegar Johansen Dagenborg, et al.. (2023). A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases. Cancer Research Communications. 3(2). 235–244. 3 indexed citations
2.
Ree, Anne Hansen, Vigdis Nygaard, Hege G. Russnes, et al.. (2019). Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain. Cancer Immunology Research. 7(5). 701–706. 5 indexed citations
3.
Aure, Miriam R. R., Mads H. Haugen, Kristine Kleivi Sahlberg, et al.. (2019). miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer. Molecular Oncology. 13(10). 2278–2296. 38 indexed citations
4.
Haugen, Mads H., Ole Christian Lingjærde, Oslo Garred, et al.. (2019). Design of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients. Annals of Oncology. 30. iii8–iii8.
5.
Prasmickaite, Lina, Solveig Pettersen, Silje Nord, et al.. (2018). Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4. Molecular Oncology. 12(9). 1540–1558. 36 indexed citations
6.
Engebraaten, Olav, Laxmi Silwal‐Pandit, Silje Nord, et al.. (2015). Molecular characteristics in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva— Randomized phase II study.. Journal of Clinical Oncology. 33(15_suppl). 2523–2523.
7.
Borge, Kaja Sverdrup, Anne‐Lise Børresen‐Dale, & Frode Lingaas. (2011). Identification of genetic variation in 11 candidate genes of canine mammary tumour. Veterinary and Comparative Oncology. 9(4). 241–250. 34 indexed citations
8.
Papp, J., et al.. (2010). High prevalence of germline STK11mutations in Hungarian Peutz-Jeghers Syndrome patients. BMC Medical Genetics. 11(1). 169–169. 32 indexed citations
9.
Murph, Mandi M., Wenbin Liu, Shuangxing Yu, et al.. (2009). Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis. PLoS ONE. 4(5). e5583–e5583. 53 indexed citations
10.
Irish, Jonathan M., Nina Ånensen, Randi Hovland, et al.. (2006). Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53. Blood. 109(6). 2589–2596. 59 indexed citations
11.
Aas, Turid, Stephanie Geisler, Geir Egil Eide, et al.. (2003). Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy. European Journal of Cancer. 39(4). 438–446. 43 indexed citations
12.
Geisler, Stephanie, Per Eystein Lønning, Turid Aas, et al.. (2001). Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.. PubMed. 61(6). 2505–12. 264 indexed citations
13.
Dai, Haiyan, Ruth Holm, Gunnar B. Kristensen, et al.. (2001). Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas. Analytical Cellular Pathology. 23(2). 45–49. 10 indexed citations
14.
Stokke, Trond, Eivind Galteland, Harald Holte, et al.. (2000). Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in b‐cell non‐Hodgkin's lymphoma. International Journal of Cancer. 89(4). 313–324. 1 indexed citations
15.
Clausen, O. P. F., Ragnhild A. Lothe, Anne‐Lise Børresen‐Dale, et al.. (1998). Association of p53 Accumulation With TP53 Mutations, Loss of Heterozygosity at 17p13, and DNA Ploidy Status in 273 Colorectal Carcinomas. Diagnostic Molecular Pathology. 7(4). 215–223. 15 indexed citations
16.
Sørlie, Thérese, I. K. Bukholm, & Anne‐Lise Børresen‐Dale. (1998). Truncating somatic mutation in exon 15 of the APC gene is a rare event in human breast carcinomas. Mutations in brief no. 179. Online.. PubMed. 12(3). 215–215. 20 indexed citations
17.
Kraggerud, Sigrid Marie, Kari Dolven Jacobsen, Trond Stokke, et al.. (1997). A Comparison of Different Modes for the Detection of p53 Protein Accumulation a Study of Bladder Cancer. Pathology - Research and Practice. 193(7). 471–478. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan C. Dentro Breakdown of academic impact, for papers by Nurten Yigit Breakdown of academic impact, for papers by J. R. Marks Breakdown of academic impact, for papers by A S Yang Breakdown of academic impact, for papers by George Koutsodontis Breakdown of academic impact, for papers by Marco Petronio Breakdown of academic impact, for papers by Zsuzsa Rákosy Breakdown of academic impact, for papers by Emily Yun‐Chia Chang Breakdown of academic impact, for papers by Daniel S. Kong Breakdown of academic impact, for papers by David Brocks
Rankless by CCL
2026